Table 1 Demographic and clinical characteristics
Characteristics | N=56 |
|---|---|
Age in years, median (IQR) a | 48 (41–54) |
Sex, n (%) | |
Female | 49 (87.5) |
Male | 7 (12.5) |
a Duration of illness before scan in days, median (IQR) | 17 (14–25) |
b Study type, n (%) | |
Q SPECT/CT scan | 47 (83.9) |
VQ SPECT/CT scan | 9 (16.1) |
b Follow-up study, n (%) | |
None | 42 (75.0) |
VQ SPECT/CT scan | 14 (25.0) |
Defects, n (%) | |
No | 24 (42.9) |
Yes | 32 (57.1) |
Mosaic attenuation, n (%) | |
No | 32 (57.1) |
Yes | 24 (42.9) |
COVID pneumonia, n (%) | |
No | 32 (57.1) |
Yes | 24 (42.9) |
b Defects from PE, n (%) | |
No | 31 (55.4) |
Yes | 20 (35.7) |
Non-diagnostic | 5 (8.9) |
b Defects with mosaic attenuation other than PE, n (%) | |
No | 39 (69.6) |
Yes | 17 (30.4) |
Defects from pulmonary infiltrates, n (%) | |
No | 50 (89.3) |
Yes | 6 (10.7) |
Shunting, n (%) | |
No | 46 (82.1) |
Yes | 10 (17.9) |